Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer?Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer?
A small group of women with advanced breast cancer received a vaccine via a clinical trial more than 20 years ago. Today, they’re all still alive. Scientists say that kind of long-term survival is almost unheard of for patients with metastatic breast cancer, and it’s what caught the attention of researchers now.
Ozempic and Wegovy protect the heart, even without weight lossOzempic and Wegovy protect the heart, even without weight loss
Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems tied not just to slimming down but to deeper biological effects on inflammation, blood pressure, and vessel health. Researchers say this could expand who Read More
WeightWatchers GLP-1 Clinic Review WeightWatchers GLP-1 Clinic Review
Post Content Post Content
Prescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or ObesityPrescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or Obesity
This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity. This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity.
GLP-1RAs and Pay-Per-Click Direct-to-Consumer AdvertisingGLP-1RAs and Pay-Per-Click Direct-to-Consumer Advertising
This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA). This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA).
Chicago father of child fighting cancer released on bond by immigration judgeChicago father of child fighting cancer released on bond by immigration judge
A Chicago man whose 16-year-old daughter is undergoing treatment for advanced cancer will be released on bond and return home, an immigration judge ruled Thursday
Study Homes In on Breast Cancer Risk With Hormonal Birth ControlStudy Homes In on Breast Cancer Risk With Hormonal Birth Control
(MedPage Today) — Use of hormonal contraceptives was associated with an increased risk of breast cancer, but the risk varied by progestin content, according to a large Swedish cohort study.
Among over 2 million adolescent girls and women, ever…
Meet “The Pink Jet” aviators on a mission to empower breast cancer patientsMeet “The Pink Jet” aviators on a mission to empower breast cancer patients
“The Pink Jet,” a nonprofit organization, is on a new mission to empower those battling breast cancer, promote screenings and raise money to find a cure. CBS News’ Natalie Morales has more.
Breast cancer risk varies between different hormonal contraceptives, research revealsBreast cancer risk varies between different hormonal contraceptives, research reveals
Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and teenage girls in Sweden to identify how different hormonal contraceptives affect the risk of breast cancer.
GLP-1 drugs effective for weight loss, but more independent studies neededGLP-1 drugs effective for weight loss, but more independent studies needed
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the use of these drugs to treat obesity. Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically Read More